PTPN3 and cancer: Of interest, PDZ binding is required for p38γ [44,47,49] and PTPH1 [50,51,52] oncogenic activity [53], as expression of their PDZ-binding-deficient mutants by stable transfection or application of peptide to disrupt the endogenous p38γ/PTPH1 interaction inhibits cancer cell growth [47].